Cyclin A2 (Ccna2), normally silenced after birth in the mammalian heart, can induce cardiac
repair in small-animal models of myocardial infarction. We report that delivery of the Ccna2 …

People in developing countries have faced multigenerational undernutrition and are currently
undergoing major lifestyle changes, contributing to an epidemic of metabolic diseases, …

Oxidative stress has been established as a well-known pathological condition in several
neurovascular diseases. It starts with increased production of highly oxidizing free-radicals (eg …

Background Coronary bypass graft failure as a result of acute thrombosis and intimal
hyperplasia has been the major challenge in surgical procedures involving small-diameter …

Neurological/neurovascular disorders constitute the leading cause of disability and the second
leading cause of death globally. Major neurological/neurovascular disorders or diseases …

Shock is a severe, life-threatening medical condition with a high mortality rate worldwide. All
four major categories of shock (along with their various subtypes)—hypovolemic, distributive…

Background: Preterm infants experience rapid brain growth during early post-natal life making
them vulnerable to drugs acting on central nervous system. Morphine is administered to …

The development of effective drugs for stroke is urgently required as it is the 2nd largest
killer in the world and its incidence is likely to increase in the future. We have demonstrated …

Neonatal hypoxic-ischemic encephalopathy (HIE) is a condition that results in brain damage
in newborns due to insufficient blood and oxygen supply during or after birth. HIE is a major …

Endothelin-B receptor agonist, IRL-1620, provides significant neuroprotection following
cerebral ischemia in rats. Whether this neuroprotection is due to inhibition of apoptosis is …